| Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κB activation O Moiseeva, X Deschênes‐Simard, E St‐Germain, S Igelmann, G Huot, ... Aging cell 12 (3), 489-498, 2013 | 546 | 2013 |
| Mitochondrial dysfunction contributes to oncogene-induced senescence O Moiseeva, V Bourdeau, A Roux, X Deschênes-Simard, G Ferbeyre Molecular and cellular biology 29 (16), 4495-4507, 2009 | 414 | 2009 |
| Metformin reduces endogenous reactive oxygen species and associated DNA damage C Algire, O Moiseeva, X Deschênes-Simard, L Amrein, L Petruccelli, ... Cancer Prevention Research 5 (4), 536-543, 2012 | 392 | 2012 |
| ERKs in cancer: friends or foes? X Deschênes-Simard, F Kottakis, S Meloche, G Ferbeyre Cancer research 74 (2), 412-419, 2014 | 250 | 2014 |
| Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation X Deschênes-Simard, MF Gaumont-Leclerc, V Bourdeau, F Lessard, ... Genes & development 27 (8), 900-915, 2013 | 208 | 2013 |
| SOCS1 links cytokine signaling to p53 and senescence V Calabrese, FA Mallette, X Deschênes-Simard, S Ramanathan, ... Molecular cell 36 (5), 754-767, 2009 | 155 | 2009 |
| Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway F Lessard, S Igelmann, C Trahan, G Huot, E Saint-Germain, L Mignacca, ... Nature cell biology 20 (7), 789-799, 2018 | 113 | 2018 |
| Cellular senescence and protein degradation: Breaking down cancer. X Deschênes-Simard, F Lessard, MF Gaumont-Leclerc, N Bardeesy, ... Cell cycle (Georgetown, Tex.) 13 (12), 1840-1858, 2014 | 70 | 2014 |
| Metformin, aging and cancer. O Moiseeva, X Deschênes-Simard, M Pollak, G Ferbeyre Aging 5 (5), 330-331, 2013 | 52 | 2013 |
| Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: a retrospective multicentric cohort study X Deschênes-Simard, C Richard, L Galland, F Blais, A Desilets, J Malo, ... Thrombosis Research 205, 29-39, 2021 | 40 | 2021 |
| Circumventing senescence is associated with stem cell properties and metformin sensitivity X Deschênes‐Simard, M Parisotto, MC Rowell, B Le Calvé, S Igelmann, ... Aging Cell 18 (2), e12889, 2019 | 38 | 2019 |
| Macrophages in pancreatic cancer: starting things off on the wrong track X Deschênes-Simard, Y Mizukami, N Bardeesy Journal of Cell Biology 202 (3), 403-405, 2013 | 15 | 2013 |
| Genome reprogramming in cells that escape from senescence X Deschênes-Simard, S Roy, G Ferbeyre Bionatura 1 (2), 54-61, 2016 | 6 | 2016 |
| Metformin turns off the metabolic switch of pancreatic cancer X Deschênes-Simard, MC Rowell, G Ferbeyre Aging (Albany NY) 11 (23), 10793, 2019 | 4 | 2019 |
| Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer MC Rowell, X Deschenes-Simard, S Lopes-Paciencia, B Le Calve, ... Cell Cycle 22 (19), 2172-2193, 2023 | 2 | 2023 |
| Tumor suppressor activity of the ERK/MAPK signaling: inhibition of cell reprogramming by degradation of specific proteins X Deschênes-Simard, F Kottakis, F Lessard, E Saint-Germain, ... Cancer Research 74 (19_Supplement), 3895-3895, 2014 | 2 | 2014 |
| Thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study. X Deschenes-Simard, L Galland, F Blais, A Desilets, J Malo, L Cvetkovic, ... Journal of Clinical Oncology 39 (15_suppl), e21198-e21198, 2021 | 1 | 2021 |
| Hyperactivation of ERK/MAPK pathway reduces pancreatic cancer cells' proliferation and tumor progression through phosphoproteome reprogramming MC Rowell, X Deschênes-Simard, BL Calvé, S Lopes-Paciência, AF Ruiz, ... Cancer Research 78 (13_Supplement), 462-462, 2018 | 1 | 2018 |
| Extracellular Signal-Regulated Kinases: One Pathway, Multiple Fates X Deschênes-Simard, M Malleshaiah, G Ferbeyre Cancers 16 (1), 95, 2023 | | 2023 |
| www. aging-us. com AGING 2019, Vol. 11, No. 23 X Deschênes-Simard, MC Rowell, G Ferbeyre AGING 11 (23), 2019 | | 2019 |
